Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
Cipepofol is being placed in Schedule IV of the Controlled Substances Act, imposing DEA registration, recordkeeping, and security requirements on pharmacies and other handlers.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 25, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that handle or dispense Cipepofol. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective date not specified in the excerpt; check the final rule for the effective date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Cipepofol becomes a Schedule IV controlled substance, requiring DEA registration, secure storage, and strict recordkeeping.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that handle or dispense Cipepofol.
What you must do
Ensure DEA registration covers Schedule IV substances, update inventory and security protocols, and train staff on new requirements.
Deadline
Effective date not specified in the excerpt; check the final rule for the effective date.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- International Drug Scheduling: Single Convention on Narcotic Drugs, Convention on Psychotropic Substances; Clobromazolam (phenazolam), Cychlorphine (N-propionitrile chlorphine), etc.
- Catina Allen, N.P.; Decision and Order
- US-CONGRESS BILLS-119hr10133ih: Fair Prescription Pricing Act of 2026
- Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
- New Colorado law allows prescription drug donations for low-income patients - Sentinel Colorado